Editorials:

A magic bullet for gout?

Alexander So and Nathalie Busso

Ann Rheum Dis 2009; 68: 1517-1519. doi:10.1136/ard.2009.112508

[Extract] [Full Text] [PDF] [Request Permissions]

Letters:

Can MRI substitute for biopsy in eosinophilic fasciitis?

M Ronneberger, R Janka, G Schett, and B Manger

Ann Rheum Dis 2009; 68: 1651-1652. doi:10.1136/ard.2008.103903

[Extract] [Full Text] [PDF] [Request Permissions]

IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis

L H D van Tuyl, W F Lems, P J S M Kerstens, A E Voskuyl, B A C Dijkmans, and M Boers

Ann Rheum Dis 2009; 68: 1652-1653. doi:10.1136/ard.2008.103184

[Extract] [Full Text] [PDF] [Request Permissions]

Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus

M D de Kruif, M Limper, H R Hansen, J de Ruiter, C A Spek, E C M van Gorp, I J ten Berge, A T Rowshani, H ten Cate, and E W Meesters

Ann Rheum Dis 2009; 68: 1654. doi:10.1136/ard.2009.109405

[Extract] [Full Text] [PDF] [Request Permissions]

Paraspinal and intraspinal calcinosis: frequent complications in patients with systemic sclerosis

T Ogawa, T Ogura, K Ogawa, A Hirata, N Hayashi, Y Izumi, and E Saito

Ann Rheum Dis 2009; 68: 1655-1656. doi:10.1136/ard.2008.104216

[Extract] [Full Text] [PDF] [Request Permissions]

Basic and translational research:

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

Z E Betteridge, H Gunawardena, H Chinoy, J North, W E R Ollier, R G Cooper, N J McHugh, and for the UK Adult Onset Myositis Immunogenetic Collaboration

Ann Rheum Dis 2009; 68: 1621-1625.
Published Online First: 17 October 2008. doi:10.1136/ard.2008.097162

[Abstract] [Full Text] [PDF] [Request Permissions]

Ankylosing spondylitis monocytes show upregulation of proteins involved in inflammation and the ubiquitin proteasome pathway

C Wright, M Edelmann, K diGleria, S Kollnberger, H Kramer, S McGowan, K McHugh, S Taylor, B Kessler, and P Bowness

Ann Rheum Dis 2009; 68: 1626-1632.
Published Online First: 24 October 2008. doi:10.1136/ard.2008.097204

[Abstract] [Full Text] [PDF] [Request Permissions] [Web only data]

COL2A1 gene polymorphisms and susceptibility to osteoarthritis of the hand in Finnish women

S Hämäläinen, S Solovieva, A Hirvonen, T Vehmas, E-P Takala, H Riihimäki, and P Leino-Arjas

Ann Rheum Dis 2009; 68: 1633-1637.
Published Online First: 19 November 2008. doi:10.1136/ard.2008.094706

[Abstract] [Full Text] [PDF] [Request Permissions]

The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus

P Kümpers, S David, M Haubitz, J Hellpap, R Horn, V Bröcker, M Schiffer, H Haller, and T Witte

Ann Rheum Dis 2009; 68: 1638-1643.
Published Online First: 17 October 2008. doi:10.1136/ard.2008.094664

[Abstract] [Full Text] [PDF] [Request Permissions]

Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway

I González-Alvaro, A M Ortiz, C Domínguez-Jiménez, A Aragón-Bodi, B Díaz Sánchez, and F Sánchez-Madrid

Ann Rheum Dis 2009; 68: 1644-1650.
Published Online First: 28 October 2008. doi:10.1136/ard.2008.096743

[Abstract] [Full Text] [PDF] [Request Permissions] [Web only data]

Clinical and epidemiological research:

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

M Rudwaleit, A G Jurik, K-G A Hermann, R Landewé, D van der Heijde, X Baraliakos, H Marzo-Ortega, M Østergaard, J Braun, and J Sieper

Ann Rheum Dis 2009; 68: 1520-1527.
Published Online First: 18 May 2009. doi:10.1136/ard.2009.110767

[Abstract] [Full Text] [PDF] [Request Permissions] [Web only appendix]

Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease

G Hatemi, A Silman, D Bang, B Bodaghi, A M Chamberlain, A Gul, M H Houman, I Kötter, I Olivieri, C Salvarani, P P Sfikakis, A Siva, M R Stanford, N Stübiger, S Yurdakul, and H Yazici

Ann Rheum Dis 2009; 68: 1528-1534.
Published Online First: 17 April 2008. doi:10.1136/ard.2008.087957

[Abstract] [Full Text] [PDF] [Request Permissions]

Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing

J S Smolen, D M van der Heijde, D Aletaha, S Xu, J Han, D Baker, and E W St Clair

Ann Rheum Dis 2009; 68: 1535-1540.
Published Online First: 28 October 2008. doi:10.1136/ard.2008.094128

[Abstract] [Full Text] [PDF] [Request Permissions]

Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study

E Harboe, A B Tjensvoll, S Maroni, L G Gøransson, O J Greve, M K Beyer, A Herigstad, J T Kvaløy, and R Omdal

Ann Rheum Dis 2009; 68: 1541-1546.
Published Online First: 17 October 2008. doi:10.1136/ard.2008.098301

[Abstract] [Full Text] [PDF] [Request Permissions]

Influence of variants of Fc receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor therapy in rheumatoid arthritis

J D Cañete, B Suárez, M V Hernández, R Sanmartí, I Rego, R Celis, C Moll, J A Pinto, F J Blanco, and F Lozano

Ann Rheum Dis 2009; 68: 1547-1552.
Published Online First: 17 October 2008. doi:10.1136/ard.2008.096982

[Abstract] [Full Text] [PDF] [Request Permissions]

Occurrence and correlates of fatigue in psoriatic arthritis

J A Husted, B D Tom, C T Schentag, V T Farewell, and D D Gladman

Ann Rheum Dis 2009; 68: 1553-1558.
Published Online First: 17 October 2008. doi:10.1136/ard.2008.098202

[Abstract] [Full Text] [PDF] [Request Permissions]

Sonographic-detected joint effusion compared with physical examination in the assessment of sacroiliac joints in spondyloarthritis

A Spadaro, A Iagnocco, G Baccano, F Ceccarelli, E Sabatini, and G Valesini

Ann Rheum Dis 2009; 68: 1559-1563.
Published Online First: 28 October 2008. doi:10.1136/ard.2008.093351

[Abstract] [Full Text] [PDF] [Request Permissions]

Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides

B Terrier, D Saadoun, D Sène, P Ghillani, Z Amoura, G Deray, B Fautrel, J-C Piette, and P Cacoub

Ann Rheum Dis 2009; 68: 1564-1571.
Published Online First: 28 October 2008. doi:10.1136/ard.2008.094714

[Abstract] [Full Text] [PDF] [Request Permissions]

Monitoring anti-TNF treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage

E A Haavardsholm, M Østergaard, H B Hammer, P Bøyesen, A Boonen, D van der Heijde, and T K Kvien

Ann Rheum Dis 2009; 68: 1572-1579.
Published Online First: 19 November 2008. doi:10.1136/ard.2008.091801

[Abstract] [Full Text] [PDF] [Request Permissions]

Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study

N Nishimoto, N Miyasaka, K Yamamoto, S Kawai, T Takeuchi, and J Azuma

Ann Rheum Dis 2009; 68: 1580-1584.
Published Online First: 19 November 2008. doi:10.1136/ard.2008.092866

[Abstract] [Full Text] [PDF] [Request Permissions]

Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure

U Møller Døhn, A Boonen, M L Hetland, M S Hansen, L S Knudsen, A Hansen, O R Madsen, M Hasselquist, J M Møller, and M Østergaard

Ann Rheum Dis 2009; 68: 1585-1590.
Published Online First: 19 November 2008. doi:10.1136/ard.2008.097048

[Abstract] [Full Text] [PDF] [Request Permissions]

The influence of socioeconomic status on the reporting of regional and widespread musculoskeletal pain: results from the 1958 British Birth Cohort Study

G J Macfarlane, G Norrie, K Atherton, C Power, and G T Jones

Ann Rheum Dis 2009; 68: 1591-1595.
Published Online First: 24 October 2008. doi:10.1136/ard.2008.093088

[Abstract] [Full Text] [PDF] [Request Permissions]

Orthopaedic surgery in 255 patients with inflammatory arthropathies: longitudinal effects on pain, physical function and health-related quality of life

H Osnes-Ringen, T K Kvien, J E Henriksen, P Mowinckel, and H Dagfinrud

Ann Rheum Dis 2009; 68: 1596-1601.
Published Online First: 24 October 2008. doi:10.1136/ard.2008.096362

[Abstract] [Full Text] [PDF] [Request Permissions] [Web only data]

Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis

R Torres, L Macdonald, S D Croll, J Reinhardt, A Dore, S Stevens, D M Hylton, J S Rudge, R Liu-Bryan, R A Terkeltaub, G D Yancopoulos, and A J Murphy

Ann Rheum Dis 2009; 68: 1602-1608.
Published Online First: 14 June 2009. doi:10.1136/ard.2009.109355

[Abstract] [Full Text] [PDF] [Request Permissions] [Web only appendix]

Dual energy computed tomography in tophaceous gout

H K Choi, A M Al-Arfaj, A Eftekhari, P L Munk, K Shojania, G Reid, and S Nicolaou

Ann Rheum Dis 2009; 68: 1609-1612.
Published Online First: 9 December 2008. doi:10.1136/ard.2008.099713

[Abstract] [Full Text] [PDF] [Request Permissions] [Web Only Data]

The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

R Terkeltaub, J S Sundy, H R Schumacher, F Murphy, S Bookbinder, S Biedermann, R Wu, S Mellis, and A Radin

Ann Rheum Dis 2009; 68: 1613-1617.
Published Online First: 26 July 2009. doi:10.1136/ard.2009.108936

[Abstract] [Full Text] [PDF] [Request Permissions] [Web only appendix]

A large multicentre analysis of CTGF –945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype

B Rueda, C Simeon, R Hesselstrand, A Herrick, J Worthington, N Ortego-Centeno, G Riemekasten, V Fonollosa, M C Vonk, F H J van den Hoogen, J Sanchez-Román, M A Aguirre-Zamorano, R García-Portales, A Pros, M T Camps, M A Gonzalez-Gay, M F Gonzalez-Escribano, M J Coenen, N Lambert, J L Nelson, T R D J Radstake, and J Martin

Ann Rheum Dis 2009; 68: 1618-1620.
Published Online First: 3 December 2008. doi:10.1136/ard.2008.100180

[Abstract] [Full Text] [PDF] [Request Permissions]